Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:certifications |
gptkb:FDA
gptkb:Health_Canada EMA |
| gptkbp:employees |
over 500
|
| gptkbp:focus |
research and development
quality assurance manufacturing clinical trials community outreach supply chain management antibiotics market access product launches business development strategic partnerships vaccines biologics hormonal therapies pharmacovigilance nutraceuticals patient support programs controlled substances injectables regulatory affairs cardiovascular drugs women's health products diabetes medications medical affairs urology products dermatology products gastrointestinal products respiratory products OTC products anti-infectives pain management products oncology products oral solid dosage forms liquid dosage forms topical dosage forms central nervous system drugs healthcare_professional_education |
| gptkbp:founded |
2003
|
| gptkbp:headquarters |
gptkb:Mississauga,_Ontario
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupin Canada
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:Canada
gptkb:North_America |
| gptkbp:parentCompany |
gptkb:Lupin_Limited
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:products |
generic drugs
branded drugs |
| gptkbp:website |
www.lupin.com
|